Monthly Archives: Ottobre 2021
Il farmaco antimicrobico Atovaquone ha un potenziale antivirale contro il coronavirus SARS-CoV-2 e i...
Una nuova ricerca multinazionale che coinvolge scienziati medici dell'Università di Aarhus-Danimarca, dell'Istituto Pasteur Italia-Fondazione Cenci Bolognetti-Italia, dell'Università di Ottawa-Canada e dell'Ottawa Hospital Research Institute-Canada...
COVID increases the risk of psychiatric and neurological effects
Suicidal thoughts, "paranoia-like fears," delusions and "foggy brain" have been identified in three adolescents who had mild or asymptomatic COVID-19. Now, a new study...
Antimicrobial drug Atovaquone has antiviral potential against the SARS-CoV-2 coronavirus and emerging VOCs
A new multinational research involving medical scientists from Aarhus University-Denmark, Istituto Pasteur Italia-Cenci Bolognetti Foundation-Italy, University of Ottawa-Canada and Ottawa Hospital Research Institute-Canada has...
Mutations at a hotspot W152 of the N-Terminal Domain (NTD) of the SARS-CoV-2 virus...
Researchers from the Data Science Department, SOPHiA GENETICS-Switzerland has found that mutations at a hotspot W152 of the N-Terminal Domain (NTD) of the SARS-CoV-2...
COVID-19: New Research Highlights N Antibody Levels Appear to Be Lower in Fully Vaccinated...
A document by the British health authorities reveals that recent observations from UK Health Security Agency (UKHSA) surveillance data indicates that N antibody levels...
SARS-CoV-2 – la principale proteasi mpro causa la patologia cerebrale microvascolare
Farmacologia clinica e tossicologia, Centro del cervello, comportamento e metabolismo (CBBM), Università di Lubecca, Lubecca-Germania hanno scoperto in modo allarmante che il mpro della proteasi principale SARS-CoV-2 causa la scissione...
The role of fat cells in cognitive decline and neurodegeneration
Findings published this week reveal new insights into the role of fat cells in cognitive decline and neurodegeneration, according to a study that involves...
SARS-CoV-2 main protease mpro causes microvascular brain pathology
Clinical Pharmacology and Toxicology, Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Lübeck-Germany has alarmingly found that the SARS-CoV-2 main protease mpro...
Diabete di tipo 2: una somministrazione di cellule muscolari ingegnerizzate può curare il diabete...
Al Technion è in fase di sviluppo un nuovo approccio al trattamento del diabete di tipo 2. La malattia, causata dall'insulino-resistenza e dalla riduzione della...
Researchers used the cold to fight multiple sclerosis
In evolutionary biology, the "life history theory," first proposed in the 1950s, postulates that when the environment is favorable, the resources used by any...
Cognitive decline and brain fog can persist up to 8 months after contracting COVID-19
A new study by researchers from Icahn School of Medicine at Mount Sinai, New York has shown that that cognitive decline and brain fog...
Il Prozac potrebbe offrire il primo trattamento contro la degenerazione maculare atrofica legata all’età
Bradley D. Gelfand, Ph.D. e collaboratori dell'UVA hanno trovato prove precoci che il farmaco fluoxetina può essere efficace contro la degenerazione maculare atrofica (o...
Type 2 diabetes: One shot of engineered muscle cell can cure diabete for four...
A novel approach to treating type 2 diabetes is being developed at the Technion. The disease, caused by insulin resistance and reduction of cells'...
I farmaci CA-074 e Camostat bloccano l’infezione da SARS-CoV-2
Il vaccino COVID-19 è solo un esempio dello sforzo rapido e globale per fermare la pandemia. Anche i farmaci sono in fase di sviluppo. Un nuovo...
Prozac could offer the first treatment against atrophic age-related macular degeneration
macular degeneration
UVA's Bradley D. Gelfand, Ph.D., and collaborators have found early evidence that the drug fluoxetine may be effective against atrophic (or "dry") age-related...
